Acumen Pharmaceuticals (ABOS) Operating Expenses (2020 - 2026)
Acumen Pharmaceuticals (ABOS) posted Operating Expenses of $21.1 million for Q1 2026, down 16.07% sequentially from $25.2 million in Q4 2025, and down 30.36% YoY from $30.4 million in Q1 2025.
Acumen Pharmaceuticals (ABOS) Operating Expenses (2020 - 2026) Analysis & Trends
Acumen Pharmaceuticals has reported Operating Expenses for 7 years, with the latest figure at $21.1 million in Q1 2026.
- Quarterly Operating Expenses fell 30.36% year-over-year to $21.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $114.6 million (down 9.48% YoY) and the FY2025 annual result came in at $123.8 million, up 8.61% from the prior year.
- Operating Expenses retreated to $21.1 million in Q1 2026 per ABOS's latest filing, from $25.2 million in the prior quarter.
- Over five years, Operating Expenses peaked at $41.8 million in Q2 2025 and troughed at $9.2 million in Q1 2022.
- A 5-year average of $21.5 million and a median of $18.5 million in 2023 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2025: Operating Expenses soared 202.56% in 2022, then sank 36.36% in 2025.
- Over 5 years, Operating Expenses stood at $14.2 million in 2022, then increased by 29.74% to $18.5 million in 2023, then soared by 114.2% to $39.6 million in 2024, then plunged by 36.36% to $25.2 million in 2025, then decreased by 16.07% to $21.1 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $21.1 million, $25.2 million, and $26.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Acumen Pharmaceuticals | 229.03 Mn | 229.03 Mn | - | 32.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.56 Mn |
| Mar 31, 2026 | 21.15 Mn |
| Dec 31, 2025 | 25.20 Mn |
| Sep 30, 2025 | 26.51 Mn |
| Jun 30, 2025 | 41.75 Mn |
| Mar 31, 2025 | 30.37 Mn |
| Dec 31, 2024 | 39.60 Mn |
| Sep 30, 2024 | 32.27 Mn |
| Jun 30, 2024 | 24.38 Mn |
| Mar 31, 2024 | 17.77 Mn |
| Dec 31, 2023 | 18.49 Mn |
| Sep 30, 2023 | 16.04 Mn |
| Jun 30, 2023 | 13.48 Mn |
| Mar 31, 2023 | 13.14 Mn |
| Dec 31, 2022 | 14.25 Mn |
| Sep 30, 2022 | 11.37 Mn |
| Jun 30, 2022 | 10.41 Mn |
| Mar 31, 2022 | 9.21 Mn |
| Dec 31, 2021 | 8.42 Mn |
| Sep 30, 2021 | 3.94 Mn |